CUE insider buying and SEC filings, explained
Cue Biopharma, Inc. · CIK 1645460
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$100K
Insiders who bought
1
Sold (not marked 10b5-1)
$912K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 12, 2026 | Sale | Sumita Ray (Chief Legal Compliance Officer and Corporate Secretary) sold 1,844 shares at $28.05 ($52K). Holdings down 2% to 116,701 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 9:39 PM ET |
| Oct 12, 2026 | Sale | Michael Vincent Meluzio (VP, Prin. Accounting Officer) sold 1,144 shares at $28.05 ($32K). Holdings down 2% to 47,817 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 9:38 PM ET |
| Oct 12, 2026 | Sale | Shao-Lee Lin (CEO and Director) sold 11,087 shares at about $27.55 ($305K). Holdings down 2% to 694,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 9:37 PM ET |
| Aug 13, 2026 | Sale | Shao-Lee Lin (CEO and Director) sold 18,258 shares at about $28.62 ($523K). Holdings down 3% to 705,995 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Jun 1, 2026 | Other purchase | Shao-Lee Lin (CEO and Director) bought 136,359 Pre-Funded Warrants (Right to Buy) in 2 share classes indirectly at $11.00 ($1.0M for the 90,906 shares with a reported price) in a private placement. New position of 90,906 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Dec 30, 2025 | Purchase (code P) | Pasha Sarraf (Director) bought 323,857 shares at about $0.3079 ($100K), reported as a purchase (code P). New position of 323,857 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 2, 2026 |
31 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CUE in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.